ScoreWhy is Klaria Pharma Holding AB ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate 5.98% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -10.64
2
Flat results in Mar 25
- INTEREST(HY) At SEK 9.18 MM has Grown at 66.3%
- ROCE(HY) Lowest at -191.23%
- CASH AND EQV(HY) Lowest at SEK 2.12 MM
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 38.56%, its profits have fallen by -21.8%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Klaria Pharma Holding AB for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Klaria Pharma Holding AB
38.56%
0.26
165.11%
OMX Stockholm 30
8.01%
0.44
18.11%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
60.86%
EBIT Growth (5y)
5.98%
EBIT to Interest (avg)
-10.64
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.90
Sales to Capital Employed (avg)
0.68
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-6.54
EV to EBIT
-4.66
EV to EBITDA
-8.41
EV to Capital Employed
-5.81
EV to Sales
11.77
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend27What is working for the Company
OPERATING CASH FLOW(Y)
Highest at SEK -3.18 MM
NET SALES(HY)
Higher at SEK 10.05 MM
RAW MATERIAL COST(Y)
Fallen by -103.34% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at -53.43 %
DEBTORS TURNOVER RATIO(HY)
Highest at 6.28%
OPERATING PROFIT(Q)
Highest at SEK 5.65 MM
PRE-TAX PROFIT(Q)
Highest at SEK -1.59 MM
NET PROFIT(Q)
Highest at SEK -1.59 MM
EPS(Q)
Highest at SEK -0.01
-7What is not working for the Company
INTEREST(HY)
At SEK 9.18 MM has Grown at 66.3%
ROCE(HY)
Lowest at -191.23%
CASH AND EQV(HY)
Lowest at SEK 2.12 MM
Here's what is working for Klaria Pharma Holding AB
Net Sales
At SEK 10.05 MM has Grown at 602.87%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (SEK MM)
Operating Cash Flow
Highest at SEK -3.18 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (SEK MM)
Pre-Tax Profit
At SEK -1.59 MM has Grown at 84.01%
over average net sales of the previous four periods of SEK -9.96 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (SEK MM)
Net Sales
Higher at SEK 10.05 MM
than preceding 12 month period ended Mar 2025MOJO Watch
In the half year the company has already crossed sales of the previous twelve months
Net Sales (SEK MM)
Operating Profit
Highest at SEK 5.65 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (SEK MM)
Pre-Tax Profit
Highest at SEK -1.59 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (SEK MM)
Net Profit
Highest at SEK -1.59 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (SEK MM)
Net Profit
At SEK -1.59 MM has Grown at 84.02%
over average net sales of the previous four periods of SEK -9.96 MMMOJO Watch
Near term Net Profit trend is positive
Net Profit (SEK MM)
EPS
Highest at SEK -0.01
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (SEK)
Debt-Equity Ratio
Lowest at -53.43 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Debtors Turnover Ratio
Highest at 6.28%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -103.34% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Klaria Pharma Holding AB
Interest
At SEK 9.18 MM has Grown at 66.3%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (SEK MM)
Cash and Eqv
Lowest at SEK 2.12 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
